AstraZeneca Aktie
150,95
EUR
-1,40
EUR
-0,92
%
152,20
EUR
+0,65
EUR
+0,43
%
AstraZeneca jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
AstraZeneca Aktie Analyse
| 03.06.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 03.06.19 | AstraZeneca Sell | UBS AG | |
| 28.05.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.05.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 24.05.19 | AstraZeneca overweight | Barclays Capital | |
| 13.05.19 | AstraZeneca Sell | UBS AG | |
| 13.05.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 10.05.19 | AstraZeneca buy | Deutsche Bank AG | |
|
Werbung
|
|||
| 10.05.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 07.05.19 | AstraZeneca Equal-Weight | Morgan Stanley | |
| 07.05.19 | AstraZeneca Sell | UBS AG | |
| 07.05.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 30.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 29.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.04.19 | AstraZeneca Sell | UBS AG | |
| 26.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 24.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 11.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.04.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 05.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 03.04.19 | AstraZeneca buy | Kepler Cheuvreux | |
| 03.04.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 02.04.19 | AstraZeneca Sell | UBS AG | |
| 02.04.19 | AstraZeneca Reduce | HSBC | |
| 01.04.19 | AstraZeneca overweight | Barclays Capital | |
| 01.04.19 | AstraZeneca Neutral | UBS AG | |
| 01.04.19 | AstraZeneca buy | Deutsche Bank AG | |
| 29.03.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 29.03.19 | AstraZeneca overweight | Barclays Capital | |
| 29.03.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.03.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.03.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 05.03.19 | AstraZeneca buy | Deutsche Bank AG | |
| 28.02.19 | AstraZeneca Reduce | HSBC | |
| 26.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 26.02.19 | AstraZeneca buy | Deutsche Bank AG | |
| 26.02.19 | AstraZeneca overweight | Barclays Capital | |
| 25.02.19 | AstraZeneca overweight | Barclays Capital | |
| 18.02.19 | AstraZeneca buy | Deutsche Bank AG | |
| 15.02.19 | AstraZeneca Outperform | Credit Suisse Group | |
| 14.02.19 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.02.19 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 14.02.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 29.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 22.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 14.01.19 | AstraZeneca buy | Deutsche Bank AG | |
| 02.01.19 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 20.12.18 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 20.12.18 | AstraZeneca overweight | JP Morgan Chase & Co. | |
Werbung
Werbung